The Politics Of Mega-Mergers: Health Care Reform And U.S. Biopharma Realignment
This article was originally published in The Pink Sheet Daily
Executive Summary
Merck/Schering, Pfizer/Wyeth underscore sense of long-term structural change in U.S. pharma market.